# The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

> **NCT00822263** · NA · COMPLETED · sponsor: **Brooke Army Medical Center** · enrollment: 150 (estimated)

## Conditions studied

- Mild Traumatic Brain Injury

## Interventions

- **DRUG:** N-acetyl-cysteine (NAC)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00822263
- **Lead sponsor:** Brooke Army Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-03
- **Final completion:** 2009-08
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2010-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822263, "The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00822263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*